DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development
DAAN Biotherapeutics, a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies, ...
Exchange operator ASX posts rise in new listings and capital growth, shares jump
Australian exchange operator ASX said on Thursday it had recorded higher new listings and total quoted capital in the first ...